In the past, various efforts in the management of the T2DM are tailored toward maintaining the glucose at a normal level via non-pharmacological interventions such as diets and exercise and pharmacologically using oral hypoglycaemic agents (OHAs) including the likes of sulphonylureas, biguanides, meglitinides, thiazolidinediones and alpha-glucosidase inhibitors. Here, GAA is linked to type 2 diabetes mellitus.